Login
Home
Charts
Search
Watchlist
Products

Bandaram Pharma Packtech Ltd

BANDARAM·BSE
20.99+1.11%Wed, 23 Sept '26 15:29

Bandaram Pharma Packtech Ltd

BANDARAM
BSE
20.99
+1.11%
|Wed, 23 Sept '26 15:29
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
38Cr
Close
Close Price
20.99
Industry
Industry
Medical Accessories/Disposables
PE
Price To Earnings
69.97
PS
Price To Sales
0.48
Revenue
Revenue
79Cr
Rev Gr TTM
Revenue Growth TTM
133.74%
PAT Gr TTM
PAT Growth TTM
42.17%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
7713117108814152624
Growth YoY
Revenue Growth YoY%
210.636.333.593.7-3.435.9-36.8-28.893.048.4209.3195.7
Expenses
ExpensesCr
771311698713142522
Operating Profit
Operating ProfitCr
001111110112
OPM
OPM%
6.46.45.44.815.26.66.47.73.46.83.16.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000100000
PBT
PBTCr
000010000101
Tax
TaxCr
000000000000
PAT
PATCr
000010000001
Growth YoY
PAT Growth YoY%
148.0-72.1-38.7157.1458.3-108.3-21.1-88.9-91.03,600.0-40.03,300.0
NPM
NPM%
1.61.61.41.69.4-0.11.80.30.42.40.32.8
EPS
EPS
0.10.10.20.10.30.00.10.00.00.10.10.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
7713117108814152624
Growth YoY
Revenue Growth YoY%
210.636.333.593.7-3.435.9-36.8-28.893.048.4209.3195.7
Expenses
ExpensesCr
771311698713142522
Operating Profit
Operating ProfitCr
001111110112
OPM
OPM%
6.46.45.44.815.26.66.47.73.46.83.16.4
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000100000
PBT
PBTCr
000010000101
Tax
TaxCr
000000000000
PAT
PATCr
000010000001
Growth YoY
PAT Growth YoY%
148.0-72.1-38.7157.1458.3-108.3-21.1-88.9-91.03,600.0-40.03,300.0
NPM
NPM%
1.61.61.41.69.4-0.11.80.30.42.40.32.8
EPS
EPS
0.10.10.20.10.30.00.10.00.00.10.10.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
01934376379
Growth
Revenue Growth%
81.98.570.2133.7
Expenses
ExpensesCr
01831346075
Operating Profit
Operating ProfitCr
013334
OPM
OPM%
6.28.37.64.64.9
Other Income
Other IncomeCr
000000
Interest Expense
Interest ExpenseCr
001121
Depreciation
DepreciationCr
011111
PBT
PBTCr
001102
Tax
TaxCr
000000
PAT
PATCr
001101
Growth
PAT Growth%
2,675.0268.04.9-54.742.2
NPM
NPM%
1.42.82.70.71.5
EPS
EPS
0.30.80.80.30.3
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
01934376379
Growth
Revenue Growth%
81.98.570.2133.7
Expenses
ExpensesCr
01831346075
Operating Profit
Operating ProfitCr
013334
OPM
OPM%
6.28.37.64.64.9
Other Income
Other IncomeCr
000000
Interest Expense
Interest ExpenseCr
001121
Depreciation
DepreciationCr
011111
PBT
PBTCr
001102
Tax
TaxCr
000000
PAT
PATCr
001101
Growth
PAT Growth%
2,675.0268.04.9-54.742.2
NPM
NPM%
1.42.82.70.71.5
EPS
EPS
0.30.80.80.30.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
73121218
Reserves
ReservesCr
00019
Current Liabilities
Current LiabilitiesCr
07121434
Non Current Liabilities
Non Current LiabilitiesCr
085910
Total Liabilities
Total LiabilitiesCr
720323976
Current Assets
Current AssetsCr
415263157
Non Current Assets
Non Current AssetsCr
456819
Total Assets
Total AssetsCr
720323976
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
73121218
Reserves
ReservesCr
00019
Current Liabilities
Current LiabilitiesCr
07121434
Non Current Liabilities
Non Current LiabilitiesCr
085910
Total Liabilities
Total LiabilitiesCr
720323976
Current Assets
Current AssetsCr
415263157
Non Current Assets
Non Current AssetsCr
456819
Total Assets
Total AssetsCr
720323976

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-1-4-5-5
Investing Cash Flow
Investing Cash FlowCr
-5-200
Financing Cash Flow
Financing Cash FlowCr
4656
Net Cash Flow
Net Cash FlowCr
-2001
Free Cash Flow
Free Cash FlowCr
-4-4-5-5
CFO To PAT
CFO To PAT%
-426.9-435.7-496.4-1,093.9
CFO To EBITDA
CFO To EBITDA%
-95.4-146.6-174.8-169.8
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-1-4-5-5
Investing Cash Flow
Investing Cash FlowCr
-5-200
Financing Cash Flow
Financing Cash FlowCr
4656
Net Cash Flow
Net Cash FlowCr
-2001
Free Cash Flow
Free Cash FlowCr
-4-4-5-5
CFO To PAT
CFO To PAT%
-426.9-435.7-496.4-1,093.9
CFO To EBITDA
CFO To EBITDA%
-95.4-146.6-174.8-169.8

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2244564238
Price To Earnings
Price To Earnings
155.246.955.9147.170.0
Price To Sales
Price To Sales
1.21.31.50.70.5
Price To Book
Price To Book
7.13.64.41.61.4
EV To EBITDA
EV To EBITDA
31.220.125.822.615.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
14.318.919.6
OPM
OPM%
6.28.37.64.64.9
NPM
NPM%
1.42.82.70.71.5
ROCE
ROCE%
-0.14.48.77.73.83.8
ROE
ROE%
-0.18.37.77.81.71.7
ROA
ROA%
-0.11.33.02.50.60.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2244564238
Price To Earnings
Price To Earnings
155.246.955.9147.170.0
Price To Sales
Price To Sales
1.21.31.50.70.5
Price To Book
Price To Book
7.13.64.41.61.4
EV To EBITDA
EV To EBITDA
31.220.125.822.615.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
14.318.919.6
OPM
OPM%
6.28.37.64.64.9
NPM
NPM%
1.42.82.70.71.5
ROCE
ROCE%
-0.14.48.77.73.83.8
ROE
ROE%
-0.18.37.77.81.71.7
ROA
ROA%
-0.11.33.02.50.60.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Bandaram Pharma Packtech Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/044o7fh2951mrxy9nn670d3f.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/25k6155zxpiuheu60arsu7qj.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/6hljyedf37tmtm6jrc6gmzxf.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/j53kayr2wevm2ab947q0l9lq.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/m2zamqb64sp0x5j6bobnqj9g.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/7df99xz980a3swg8br48npey.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/solad4l6nbawiy2qvcbmu5nv.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/w94e7mcljrkmpxwdzae61um1.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/x991cy78dwok29lvzd2c51zp.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/x8tnw4wfijywxo3b1byldx5l.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/0ma0n9c3f8c94csj2mbf63vn.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/nw5zth3halc0vtlk7u8a2zb2.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/2nhldp7v8npsv5fljv5v2utx.pdf